Washington Roundup
Executive Summary
The latest medical device regulatory and reimbursement news from Elsevier Business Intelligence's "The Gray Sheet."
You may also be interested in...
Device Trends To Watch In 2012
For much of the device industry, 2011 was marked by continuing change across the medtech ecosystem, most notably in the economy, the regulatory process, and the financing/innovation model. For 2012, we predict more of the same: the only certainty is continuing uncertainty.
The Interventional Suite Of The Future
The cardiac interventional suite has historically been a setting where high-tech, cutting-edge tools are welcomed. But with hospitals scrutinizing expenditures more closely than ever before, such tools must now prove themselves. Hospitals looking to build new interventional suites, or modernize old ones, are placing a premium on technologies that can improve safety, efficiency, and flexibility while streamlining workflow. A handful of companies are now offering products designed to meet these needs, and providers are starting to take notice.
The Interventional Suite Of The Future
The cardiac interventional suite has historically been a setting where high-tech, cutting-edge tools are welcomed. But with hospitals scrutinizing expenditures more closely than ever before, such tools must now prove themselves. Hospitals looking to build new interventional suites, or modernize old ones, are placing a premium on technologies that can improve safety, efficiency, and flexibility while streamlining workflow. A handful of companies are now offering products designed to meet these needs, and providers are starting to take notice.